{"task_id": "07565ed3ba7806c7", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 866/905)", "text": "osis. J Manag Care Spec Pharm 2017; 23(3):S17\u2013S24.\n\n--- Page 872 ---\n858\nReferences\nChapter 5: Endocrinology\n1 Simpson RW, Shaw JE, Zimmet PZ. The prevention of type 2 diabetes\u2014lifestyle change or pharmaco-\ntherapy? A challenge for the 21st century. Diabetes Res Clin Pract 2003; 59(3):165\u201380. http://www.ncbi.nlm.\nnih.gov/m/pubmed/12590013/\n2 Cartwright RD. The role of sleep in changing our minds: a psychologist\u2019s discussion of papers on memory \nreactivation and consolidation in sleep. Learn Mem 2004; 11(6):660\u20133. https://www.ncbi.nlm.nih.gov/pmc/\narticles/PMC534693/\n3 Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003; \n148(1):1\u20139. http://www.eje-online.org/content/148/1/1.long\n4 Gale E. Is there really an epidemic of type 2 diabetes? Lancet 2003; 362:503\u20134. http://www.thelancet.com/\njournals/lancet/article/PIIS0140-6736(03)14148-7/abstract\n5 Inoue K, Matsumoto M, Akimoto K. Fasting plasma glucose and HbA1c as risk factors for type 2 diabetes. \nDiabet Med 2008; 25(10):1157\u201363. http://onlinelibrary.wiley.com/doi/10.1111/j.1464-5491.2008.02572.x/abstract\n6 Westman EC, Yancy WS Jr, Mavropoulos JC, et al. The eff ect of a low-carbohydrate, ketogenic diet \nversus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond) 2008; \n5:36. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633336/\n7 Hemmingsen B, Lund SS, Gluud C, et al. Intensive glycaemic control for patients with type 2 diabetes: \nsystematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ 2011; \n343:d6898. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223424/\n8 Zinman B, Lachin JM, Inzucchi SE. Empagli\ufb02 ozin, cardiovascular outcomes, and mortality in type 2 diabe-\ntes. N Engl J Med 2015; 373(22):2117\u201328. http://www.nejm.org/doi/full/10.1056/NEJMc1600827\n9 Dose Adjustment For Normal Eating (DAFNE). http://www.dafne.uk.com/\n10 The Diabetes Control and Complications Trial Research Group. The eff ect of intensive treatment of \ndiabetes on the development and progression of long-term complications in insulin-dependent diabetes \nmellitus. N Engl J Med 1993; 329(14):977\u201386. http://www.nejm.org/doi/full/10.1056/NEJM199309303291401\n11 Belch J. Aspirin does not help as primary prevention in DM. BMJ 2008; 337:a1840. http://www.bmj.com/\ncgi/content/full/337/oct16_2/a1840\n12 Davidson MB, Wong A, Hamrahian AH, et al. Eff ect of spironolactone therapy on albuminuria in pa-\ntients with type 2 diabetes treated with angiotensin-converting enzyme inhibitors. Endocr Pract 2008; \n14(8):985\u201392. http://journals.aace.com/doi/abs/10.4158/EP.14.8.985\n13 NICE. Chronic kidney disease: Early identi\ufb01 cation and management of chronic kidney disease in \nadults in primary and secondary care [CG73]. https://www.nice.org.uk/guidance/cg73\n14 Murad MH, Coto-Yglesias F, Wang AT, et al. Clinical review: drug-induced hypoglycemia: a systematic \nreview. J Clin Endocrinol Metab 2009; 94(3):741\u20135. http://press.endocrine.org/doi/pdf/10.1210/jc.2008-1416\n15 Kapoor RR, James C, et al. Advances in the diagnosis and management of hyperinsulinemic hypogly-\ncemia. Nat Clin Pract Endocrinol Metab 2009; 5(2):101\u201312. http://www.nature.com/nrendo/journal/v5/n2/\nfull/ncpendmet1046.html\n16 Geraghty M, Draman M, Moran D, et al. Hypoglycaemia in an adult male: a surprising \ufb01 nding in pursuit \nof insulinoma. Surgeon 2008; 6(1):57\u201360\n17 Abraham P, Avenell A, Park CM, et al. A systematic review of drug therapy for Graves\u2019 hyperthyroidism. \nEur J Endocrinol 2005; 153(4):489\u201398. http://www.eje-online.org/content/153/4/489.long\n18 Kahaly GJ, Pitz S, Hommel G, et al. Randomized, single blind trial of intravenous versus oral steroid \nmonotherapy in Graves\u2019 orbitopathy. J Clin Endocrinol Metab 2005; 90(9):5234\u201340. http://press.endocrine.\norg/doi/pdf/10.1210/jc.2005-0148\n19 Hedback G, Od\u00e9n A. Recurrence of hyperparathyroidism; a long-term follow-up after surgery for prima-\nry hyperparathyroidism. Eur J Endocrinol 2003; 148(4):413\u201321. http://www.eje-online.org/content/148/4/413.\nlong \n20 Hoff  AO, Cote GJ, Gagel RF. Multiple endocrine neoplasias. Annu Rev Physiol 2000; 62:377. http://www.\nannualreviews.org/doi/pdf/10.1146/annurev.physiol.62.1.377 \n21 Renehan AG, Brennan BM. Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endo-\ncrinol Metab 2008; 22(4):639\u201357. http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=18971124&from=cqsr\n22 Etxabe J, Vazquez JA. Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach. Clin \nEndocrinol 1994; 40:479\u201384. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2265.1994.tb02486.x/abstract\n23 Brosnan CM, Gowing NF. Addison\u2019s disease. BMJ 1996; 312(7038):1085\u20137. https://www.ncbi.nlm.nih.gov/\npmc/articles/PMC2350885/\n24 State Coroner for Western Australia. Failure to diagnose: Addison\u2019s disease. 2007. http://www.racgp.\norg.au/afp/200710/200710bird.pdf\n25 Boyle JG, Davidson DF, Perry CG, et al. Comparison of diagnostic accuracy of urinary free metane-\nphrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheo-\nchromocytoma. J Clin Endocrinol Metab 2007; 92(12):4602\u20138. http://press.endocrine.org/doi/pdf/10.1210/\njc.2005-2668\n26 Herrmann HC, Chang G, Klugherz BD, et al. Hemodynamic eff ects of sildena\ufb01 l in men with severe \ncoronary artery disease. N Engl J Med 2000; 342(22):1622\u20136. http://www.nejm.org/doi/full/10.1056/\nNEJM200006013422201\n27 Minniti G, Gilbert DC, Brada M. Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord \n2009; 10(2):135\u201344. http://link.springer.com/article/10.1007%2Fs11154-008-9106-0 \n28 Chanson P. Acromegaly. Presse Med 2009; 38(1):92\u2013102. https://www.ncbi.nlm.nih.gov/pubmed/19004612\nChapter 6: Gastroenterology\n1 Al Moutran H. Microstomia. Medscape. 2015. http://www.emedicine.com/ent/topic148.htm\n2 Batur P, Stewart WJ, Isaacson JH. Increased prevalence of aortic stenosis in patients with arteriovenous \nmalformations of the gastrointestinal tract in Heyde syndrome. Arch Intern Med 2003; 163(15):1821\u20134. \nhttp://jamanetwork.com/journals/jamainternalmedicine/fullarticle/755859\n3 Unlugenc H, Guler T, Gunes Y, Isik G. Comparative study of the antiemetic effi  cacy of ondansetron, propo-\nfol and midazolam in the early postoperative period. Eur J Anaesthesiol 2004; 21(1):60\u20135. http://pubmedhh.\nnlm.nih.gov/cgi-bin/abstract.cgi?id=14768925&from=cqsr", "text_length": 6400, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 866/905)", "type": "chunk", "chunk_index": 865, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.678059", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.678828", "status": "complete", "chunks_added": 4}